Google Übersetzer
Bioaffinity Technologies, Inc.
About
Bioaffinity Technologies, Inc. (NASDAQ:BIAF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16
Apr 1 2026
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
Mar 25 2026
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice
Mar 17 2026
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
Mar 13 2026
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
Recent Videos
BIAF Stock Analysis Today BioAffinity Technologies Stock Prediction & Price Target
Apr 20, 2026
BIAF Stock Analysis Today BioAffinity Technologies Stock Prediction & Price Target
Apr 20, 2026
BIAF STOCK : FRESH MOMENTUM | BIOAFFINITY TECHNOLOGIES STOCK
Apr 16, 2026
bioAffinity Technologies Roundtable on Integrating CyPath® Lung into Pulmonary Practice | April 08
Apr 09, 2026
Financials
Revenue
$6.16 M
Market Cap
$18.8 M
EPS
-8.66
